The Kaplan–Meier analysis showed a meaningfully different and borderline significant risk of CVD/mortality for patients with proteinuria >1 g/d at baseline ( P = 0.05; Figure 2 A).
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
VGF showed a different pattern with evidently lower values in patients with AD dementia than in control subjects (β = −0.46 [SE 0.19]) and in patients with MCI (−0.93 [SE 0.22]), whereas the difference between patients with MCI and control subjects was only borderline significant (β = 0.47 [SE 0.20], p = 0.05).
Egger's tests were borderline significant ( P = 0.05) or statistically significant ( P = 0.03), respectively. discussion The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.
There was a borderline significant relationship between higher levels of donor INS ‐cfDNA and lower islet yield [−0.38 (0.18), p = .050] (Table 2 ).
For agility, the effect size was borderline significant (SMD = 0.65, 95% CI [0.00, 1.30], p = 0.05), suggesting only a possible positive trend.
A borderline significant increase was recorded in target segment revascularization with FFR in the RCA (adjusted HR, 1.46; 95% CI, 1.00-2.15; P = .05).
Domestication status was borderline significant in explaining variation in alpha (p-value = 0.05) and beta diversity (p-value = 0.06) of rhizosphere bacterial communities from the field study (S6 Table in S1 File ).
Secondary analyses Comparisons between individuals with high relative to low maternal cigarette consumption demonstrated a borderline significant reduction in second trimester BPD z score for the high compared to the low consumption group (four populations, mean reduction 0.09 [0, 0.19] p = 0.05) ( S3 Table ) and also for third trimester BPD z score (three populations, mean reduction 0.15 [0.03, 0.26] p = 0.01) and FL z score (three populations, mean reduction 0.17 [0.06, 0.28] p = 0.003), S4 Table .
While mortality between the cohorts remained unchanged, the combined stroke/TIA risk converged with the passage of time: at 2 years, the risk was borderline significant (11.2% vs. 6.5%, p = 0.05) [ 16 ], and at 5 years the risk was equivalent between the groups (15.9% vs. 14.7%, p = 0.35) [ 17 ].
One variable, lower-limb extension strength showed a borderline significant difference ( p = .05), with excluded participants presenting lower baseline values ( Supplementary Table S1 ).
patient non-rehabilitation visits were higher among those with unchanged pre-frail or frail status (odds ratios [OR]: 1.94, 95% confidence interval [CI]: 1.02–3.71 and OR: 1.99, 95% CI: 1.04–3.79, respectively), and among those with deteriorated frailty status (OR: 2.01, 95% CI: 0.97–4.18, p = 0.06 borderline significant, and OR: 2.05, 95% CI: 0.99–4.26, p = 0.05 borderline significant, respectively); but not for risks of hospital admission and emergency room visits if unchanged robust status was used as the reference group (Table 4 ).
However, when the correction rate in the 2 groups was compared, it was borderline significant in the treatment group (p = 0.05).
The same pattern for gazing while listening was borderline significant ( F (1, 57) = 4.00, p = .050, partial ɳ 2 = .07).
For NEUTs, a borderline significant decrease was observed between points II and III ( p = 0.05).
There was a borderline significant effect of IAT [ F (2, 60) = 3.141, p = 0.050], because of the slightly larger D score in IAT 3, described above.
For instance, the negative and borderline significant path from COMP to PU (β = -0.14, p = 0.050) challenges conventional TAM/TOE expectations.
5 C – H ); however, PR4 up-regulation was only borderline significant ( P = 0.05).
There was a borderline significant overall effect of treatment ( F 1, 1.18 = 82.59, P = 0.05).
The presence of CC was more common in TB cases, but the difference was borderline significant (P=0.05).
Our analysis demonstrated a 32% reduction in sudden cardiac death risk (RR: 0.68 [0.49–0.93], p = 0.02), which closely aligns with Liao et al.’s borderline significant finding of a 33% reduction (RR: 0.67 [0.44–1.01], p = 0.05).
Serine and free carnitine (C0) showed a borderline significant inverse association with endometrial cancer risk (OR 1SD : 0.89, 95% CI: 0.79–1.00, P-value =0.05, Perm-Pvalue = 1.00 and OR 1SD : 0.91, 95% CI: 0.81–1.00, P-value =0.07, Perm-Pvalue = 0.82, respectively).
The model including ART, maternal age and height, primiparity, labor and multiple gestation was borderline significant (adjusted R 2 0.112, p = 0.05) and ART and multiparity were the only statistically significant contributors to the variance of CDKN1C levels.
A borderline significant correlation was present when exciting with 440 nm (r = 0.57, p = 0.05) and 750 nm (r = 0.55, p = 0.06).
There was a positive correlation between consumption of fatty fish and vitamin D status ( p < 0.0001) and a borderline significant correlation between consumption of lean fish and vitamin D status ( p = 0.05).
The only borderline significant (treatment effect = 1.2; 95% CI, 0.0-2.4; P = .05) differences seen in these sensitivity analyses were between the groups receiving 400 mg and 200 mg minocycline hydrochloride.